Copyright
©The Author(s) 2022.
World J Clin Cases. May 26, 2022; 10(15): 4971-4984
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4971
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4971
Age | Gender | Involved sites | Number | Proportion | Clinical presentation | Number | Proportion | IHC/ Phenotype/Molecular | ||||
Positive | Negative | |||||||||||
< 45 | 15 | Male | 19 | Small intestine | 18 | 62.10% | Chronic abdominal pain | 11 | 37.90% | CD2 | 17 | 0 |
CD3 | 29 | 0 | ||||||||||
Colon | 14 | 48.30% | CD4 | 0 | 18 | |||||||
Diarrhea | 14 | 48.30% | CD5 | 25 | 3 | |||||||
Stomach | 6 | 20.70% | CD7 | 17 | 3 | |||||||
≥ 45 | 14 | Female | 10 | CD8 | 29 | 0 | ||||||
Oral cavity | 4 | 13.80% | Weight loss | 6 | 20.70% | CD56 | 0 | 25 | ||||
TCRαβ | 21 | 0 | ||||||||||
Esophagus | 4 | 13.80% | T1A1 | 23 | 2 | |||||||
EBER | 1 | 14 |
- Citation: Weng CY, Ye C, Fan YH, Lv B, Zhang CL, Li M. CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature. World J Clin Cases 2022; 10(15): 4971-4984
- URL: https://www.wjgnet.com/2307-8960/full/v10/i15/4971.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i15.4971